Literature DB >> 19412810

Metastatic adamantinoma responds to treatment with receptor tyrosine kinase inhibitor.

Arkadiusz Z Dudek1, Pradeep K Murthaiah, Michael Franklin, Alexander M Truskinovsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19412810     DOI: 10.3109/02841860902913579

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  4 in total

1.  Multifocal adamantinoma simulating traumatic pathology on bone scanning.

Authors:  Muhammad Babar Imran; Muhammad Naeem
Journal:  Rheumatol Int       Date:  2010-07-28       Impact factor: 2.631

2.  Rapidly Progressive Classic Adamantinoma of the Spine: Case Report and Literature Review.

Authors:  Yan Lou; Ying Li; Lei Xu; Xiaoping Jing; Su Chen; Minglei Yang; Hongyu Jiang; Chenglong Zhao; Haifeng Wei; Jianru Xiao
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

3.  A Case of Metastatic Adamantinoma That Responded Well to Sunitinib.

Authors:  Andrew D Liman; Agnes K Liman; Jenna Shields; Becky Englert; Rashmikant Shah
Journal:  Case Rep Oncol Med       Date:  2016-08-17

4.  First Confirmed Metastatic Adamantinoma of the Spine: Case Report and Literature Review.

Authors:  Ruben A Morales Ciancio; Alessandro Gasbarrini; Stefano Boriani; Marco Gambarotti
Journal:  Global Spine J       Date:  2014-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.